Sign in

CIK 0002114044 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Hemab Therapeutics Holdings, Inc.

Sign in to watch
Ticker
COAG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
414241952
Phone
45 2138 7627
Business address
101 MAIN STREET, SUITE 1220, CAMBRIDGE, MA, 02142
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. S-1MEF Other S-1MEF
  6. CERT Other Certification
  7. S-1/A Offering Registration Statement
  8. S-1/A Offering Registration Statement
  9. 8-A12B Other Registration of Securities
  10. S-1/A Offering Registration Statement
  11. S-1 Offering Registration Statement
  12. DRS/A Other Draft Registration Statement
  13. DRS Other Draft Registration Statement

Page 3 of 3 · 53 filings